Literature DB >> 17710551

Introduction to the Hepatic Encephalopathy Scoring Algorithm (HESA).

Tarek I Hassanein1, Robin C Hilsabeck, William Perry.   

Abstract

A primary obstacle to early diagnosis and treatment of hepatic encephalopathy (HE) is the lack of a well-validated, standardized assessment method. The purpose of this study was to present preliminary validity data on a new method of grading HE, the Hepatic Encephalopathy Scoring Algorithm (HESA), which combines clinical impressions with neuropsychological performances to characterize HE. Participants were 49 inpatients admitted for complications of end stage liver disease. Each participant's level of HE was graded using HESA and the West Haven Criteria (WHC) by independent raters blinded to each other's rating. A moderately strong association was found between the two grading methods (r = 0.60), and individual HESA clinical and neuropsychological indicators were good discriminators among grades. The results also suggest HESA may be more sensitive to mental status impairment in the middle grades of HE than WHC. These findings suggest HESA holds promise as a multi-method approach to grading all levels of HE.

Entities:  

Mesh:

Year:  2007        PMID: 17710551     DOI: 10.1007/s10620-007-9895-0

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  15 in total

1.  Comparative reliability and validity of chronic pain intensity measures.

Authors:  M P Jensen; J A Turner; J M Romano; L D Fisher
Journal:  Pain       Date:  1999-11       Impact factor: 6.961

Review 2.  Neuropsychological characterization of hepatic encephalopathy.

Authors:  K Weissenborn; J C Ennen; H Schomerus; N Rückert; H Hecker
Journal:  J Hepatol       Date:  2001-05       Impact factor: 25.083

Review 3.  Characteristics of minimal hepatic encephalopathy.

Authors:  Piero Amodio; Sara Montagnese; Angelo Gatta; Marsha Y Morgan
Journal:  Metab Brain Dis       Date:  2004-12       Impact factor: 3.584

Review 4.  Methods for diagnosing hepatic encephalopathy in patients with cirrhosis: a multidimensional approach.

Authors:  Sara Montagnese; Piero Amodio; Marsha Y Morgan
Journal:  Metab Brain Dis       Date:  2004-12       Impact factor: 3.584

5.  Hepatic encephalopathy--definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998.

Authors:  Peter Ferenci; Alan Lockwood; Kevin Mullen; Ralph Tarter; Karin Weissenborn; Andres T Blei
Journal:  Hepatology       Date:  2002-03       Impact factor: 17.425

6.  The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS): preliminary clinical validity.

Authors:  C Randolph; M C Tierney; E Mohr; T N Chase
Journal:  J Clin Exp Neuropsychol       Date:  1998-06       Impact factor: 2.475

7.  Clinical correlation of neuropsychological tests with 1H magnetic resonance spectroscopy in hepatic encephalopathy.

Authors:  A Huda; B H Guze; A Thomas; M Bugbee; L Fairbanks; T Strouse; F I Fawzy
Journal:  Psychosom Med       Date:  1998 Sep-Oct       Impact factor: 4.312

8.  Hepatic encephalopathy: nomenclature, pathogenesis and treatment.

Authors:  J C Quero Guillén; I Carmona Soria; J M García Montes; M Jiménez Sáenz; J M Herrerías Gutiérrez
Journal:  Rev Esp Enferm Dig       Date:  2003-02       Impact factor: 2.086

9.  Subclinical hepatic encephalopathy impairs daily functioning.

Authors:  M Groeneweg; J C Quero; I De Bruijn; I J Hartmann; M L Essink-bot; W C Hop; S W Schalm
Journal:  Hepatology       Date:  1998-07       Impact factor: 17.425

10.  Randomized controlled study of extracorporeal albumin dialysis for hepatic encephalopathy in advanced cirrhosis.

Authors:  Tarek I Hassanein; Flemming Tofteng; Robert S Brown; Brendan McGuire; Patrick Lynch; Ravindra Mehta; Fin S Larsen; Jeff Gornbein; Jan Stange; Andres T Blei
Journal:  Hepatology       Date:  2007-12       Impact factor: 17.425

View more
  19 in total

1.  Overt hepatic encephalopathy: development of a novel clinician reported outcome tool and electronic caregiver diary.

Authors:  J S Bajaj; R T Frederick; N M Bass; M Ghabril; K Coyne; M K Margolis; M Santoro; D F Coakley; M Mokhtarani; M Jurek; B F Scharschmidt
Journal:  Metab Brain Dis       Date:  2016-06-09       Impact factor: 3.584

Review 2.  Current and future diagnosis of hepatic encephalopathy.

Authors:  Jasmohan S Bajaj
Journal:  Metab Brain Dis       Date:  2010-03-06       Impact factor: 3.584

Review 3.  Definition and nomenclature of hepatic encephalopathy.

Authors:  Narayan Dharel; Jasmohan S Bajaj
Journal:  J Clin Exp Hepatol       Date:  2014-11-28

Review 4.  Resting-state functional magnetic resonance imaging in hepatic encephalopathy: current status and perspectives.

Authors:  Long Jiang Zhang; Shengyong Wu; Jiaqian Ren; Guang Ming Lu
Journal:  Metab Brain Dis       Date:  2014-02-22       Impact factor: 3.584

Review 5.  Challenges in diagnosing hepatic encephalopathy.

Authors:  K Weissenborn
Journal:  Neurochem Res       Date:  2014-08-21       Impact factor: 3.996

Review 6.  Pathogenesis, diagnosis, and treatment of hepatic encephalopathy.

Authors:  Dileep K Atluri; Ravi Prakash; Kevin D Mullen
Journal:  J Clin Exp Hepatol       Date:  2011-11-09

Review 7.  Useful tests for hepatic encephalopathy in clinical practice.

Authors:  Eiman Nabi; Jasmohan S Bajaj
Journal:  Curr Gastroenterol Rep       Date:  2014-01

8.  Pharmacotherapies that specifically target ammonia for the prevention and treatment of hepatic encephalopathy in adults with cirrhosis.

Authors:  Harry D Zacharias; Antony P Zacharias; Lise Lotte Gluud; Marsha Y Morgan
Journal:  Cochrane Database Syst Rev       Date:  2019-06-17

9.  Modified-orientation log to assess hepatic encephalopathy.

Authors:  M Salam; S Matherly; I S Farooq; R T Stravitz; R K Sterling; A J Sanyal; D P Gibson; J B Wade; L R Thacker; D M Heuman; M Fuchs; P Puri; V Luketic; S J Bickston; J S Bajaj
Journal:  Aliment Pharmacol Ther       Date:  2012-02-21       Impact factor: 8.171

10.  Use of bispectral index monitoring for a patient with hepatic encephalopathy requiring living donor liver transplantation: a case report.

Authors:  Hirobumi Okawa; Tomoko Ono; Eiji Hashiba; Toshihito Tsubo; Hironori Ishihara; Kazuyoshi Hirota
Journal:  J Anesth       Date:  2010-12-03       Impact factor: 2.078

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.